Short Interest in Integrated BioPharma Inc. (OTCMKTS:INBP) Rises By ∞

Integrated BioPharma Inc. (OTCMKTS:INBPGet Free Report) saw a significant increase in short interest in August. As of August 31st, there was short interest totaling 4 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average daily trading volume, of 12,617 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Integrated BioPharma Price Performance

Shares of OTCMKTS INBP opened at $0.17 on Thursday. The business has a 50-day moving average of $0.17 and a two-hundred day moving average of $0.21. The company has a market capitalization of $5.27 million, a price-to-earnings ratio of -2.43 and a beta of 0.40. Integrated BioPharma has a 1 year low of $0.14 and a 1 year high of $0.42.

About Integrated BioPharma

(Get Free Report)

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.

Featured Stories

Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.